For the year ending 2025-12-31, ANRO has $184,689K in assets. $33,547K in debts. $176,484K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cashand cash equivalents | 176,484 | |||
| Prepaid expenses and other current assets | 1,234 | |||
| Total current assets | 177,718 | |||
| Restricted cash | 500 | |||
| Property and equipment, net | 1,872 | |||
| Operating right-of-use asset | 4,261 | |||
| Other assets | 338 | |||
| Total assets | 184,689 | |||
| Accounts payable | 1,878 | |||
| Accrued expenses and other current liabilities | 8,862 | |||
| Term loan, current | 585 | |||
| Total current liabilities | 11,325 | |||
| Term loan,non-current | 16,172 | |||
| Convertible grant agreement | 2,227 | |||
| Lease liability, long-term | 3,823 | |||
| Total liabilities | 33,547 | |||
| Common stock (par value 0.0001), 500,000 shares authorized 31,924 and 26,987 shares issued and outstanding as of december31, 2025 and 2024 | 3 | |||
| Additionalpaid-incapital | 352,751 | |||
| Accumulated deficit | -201,634 | |||
| Accumulated other comprehensive loss | 22 | |||
| Total stockholders equity | 151,142 | |||
| Total liabilitiesand stockholders equity | 184,689 | |||
Alto Neuroscience, Inc. (ANRO)
Alto Neuroscience, Inc. (ANRO)